Epidemic and Emerging Coronaviruses (Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome)
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Bats are the natural reservoirs of severe acute respiratory syndrome (SARS)-like coronaviruses (CoVs) and likely the reservoir of Middle East respiratory syndrome (MERS)-CoV. The clinical features of SARS-CoV infection and MERS-CoV infection are similar but MERS-CoV infection progresses to respiratory failure more rapidly. Although the estimated pandemic potential of MERS-CoV is lower than that of SARS-CoV, the case fatality rate of MERS is higher. The transmission route and the possibility of other intermediary animal sources remain uncertain among many sporadic primary cases. Clinical trial options for MERS-CoV infection include monotherapy and combination therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574
Angiotensin-converting enzyme 2 protects from severe acute lung failure
Imai, Y., Kuba, K., Rao, S., Huan, Y., Guo, F., Guan, B., Yang, P., Sarao, R., Wada, T., Leong-Poi, H., et al. (2005) · Nature · doi:10.1038/nature03712 · Cited by 2,453
Peiris, J., Chu, C., Cheng, V., Chan, K., Hung, I., Poon, L., Law, K., Tang, B., Hon, T., Chan, C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13412-5 · Cited by 2,375
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
Raj, V. S., Mou, H., Smits, S. L., Dekkers, D. H. W., Müller, M. A., Dijkman, R., Muth, D., Demmers, J. A. A., Zaki, A., Fouchier, R. A. M., et al. (2013) · Nature · doi:10.1038/nature12005 · Cited by 2,061 · cited 5×
“Bats seem the common natural source of both SARS-CoV and MERS-CoV.”
BackgroundInfluentialAssiri, A., Al-Tawfiq, J. A., Al-Rabeeah, A. A., Al-Rabiah, F. A., Al-Hajjar, S., Al-Barrak, A., Flemban, H., Al-Nassir, W. N., Balkhy, H. H., Al-Hakeem, R. F., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70204-4 · Cited by 1,435
Hospital outbreak of Middle East respiratory syndrome coronavirus
Assiri, A., McGeer, A., Perl, T. M., Price, C. S., Al Rabeeah, A. A., Cummings, D. A. T., Alabdullatif, Z. N., Assad, M., Almulhim, A., Makhdoom, H., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1306742 · Cited by 1,196
Saad, M., Omrani, A. S., Baig, K., Bahloul, A., Elzein, F., Matin, M. A., Selim, M. A. A., Mutairi, M. A., Nakhli, D. A., Aidaroos, A. Y. A., et al. (2014) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2014.09.003 · Cited by 486
SARS-like WIV1-CoV poised for human emergence
Menachery, V. D., Yount, B. L., Sims, A. C., Debbink, K., Agnihothram, S. S., Gralinski, L. E., Graham, R. L., Scobey, T., Plante, J. A., Royal, S. R., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1517719113 · Cited by 418
A review of studies on animal reservoirs of the SARS coronavirus
Shi, Z., & Hu, Z. (2008) · Virus Research · doi:10.1016/j.virusres.2007.03.012 · Cited by 400 · cited 3×
“These bat SARS-like CoVs shared 88% to 92% sequence homology with human or civet isolates and the data suggest that bats could be a natural reservoir of a close ancestor of SARS-CoV.(16)”
BackgroundInfluential
Research works printed but not linked: 129
- Zumla, 2016, Coronaviruses - drug discovery and therapeutic options, Nat Rev Drug Discov, 15, 327, 10.1038/nrd.2015.37 · DOI · Paper page
- Ksiazek, 2003, A novel coronavirus associated with severe acute respiratory syndrome, N Engl J Med, 348, 1953, 10.1056/NEJMoa030781 · DOI · Paper page
- Kuiken, 2003, Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome, Lancet, 362, 263, 10.1016/S0140-6736(03)13967-0 · DOI · Paper page
- Lee, 2003, A major outbreak of severe acute respiratory syndrome in Hong Kong, N Engl J Med, 348, 1986, 10.1056/NEJMoa030685 · DOI · Paper page
- Tsang, 2003, A cluster of cases of severe acute respiratory syndrome in Hong Kong, N Engl J Med, 348, 1977, 10.1056/NEJMoa030666 · DOI · Paper page
- Zhao, 2003, Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China, J Med Microbiol, 52, 715, 10.1099/jmm.0.05320-0 · DOI · Paper page
- Xu, 2004, Epidemiologic clues to SARS origin in China, Emerg Infect Dis, 10, 1030, 10.3201/eid1006.030852 · DOI · Paper page
- Zhong, 2003, Epidemiology and cause of severe acute respiratory syndrome in Guangdong, People’s Republic of China, in Feb 2003, Lancet, 362, 1353, 10.1016/S0140-6736(03)14630-2 · DOI · Paper page
- Du, 2004, Analysis on the characteristics of blood serum Ab-IgG detective result of severe acute respiratory syndrome patients in Guangzhou, China, Zhonghua Liu Xing Bing Xue Za Zhi, 25, 925
- Guan, 2003, Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China, Science, 302, 276, 10.1126/science.1087139 · DOI · Paper page
- Wang, 2005, SARS-CoV infection in a restaurant from palm civet, Emerg Infect Dis, 11, 1860, 10.3201/eid1112.041293 · DOI · Paper page
- Song, 2005, Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human, Proc Natl Acad Sci U S A, 102, 2430, 10.1073/pnas.0409608102 · DOI · Paper page
- Lau, 2005, Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats, Proc Natl Acad Sci, 102, 14040, 10.1073/pnas.0506735102 · DOI · Paper page
- Li, 2005, Bats are natural reserviors of SARS-like coronaviruses, Science, 310, 676, 10.1126/science.1118391 · DOI · Paper page
- Chan, 2004, Persistent infection of SARS coronavirus in colonic cells in vitro, J Med Virol, 74, 1, 10.1002/jmv.20138 · DOI
- Simmons, 2005, Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry, Proc Natl Acad Sci, 102, 11876, 10.1073/pnas.0505577102 · DOI · Paper page
- Law, 2005, The 3a protein of severe acute respiratory syndrome-associated coronavirus induces apoptosis in Vero E6 cells, J Gen Virol, 86, 1921, 10.1099/vir.0.80813-0 · DOI · Paper page
- Tan, 2004, Over expression of 7a, a protein specifically encoded by the severe acute respiratory syndrome coronavirus, induces apoptosis via a caspase-dependent pathway, J Virol, 78, 14043, 10.1128/JVI.78.24.14043-14047.2004 · DOI · Paper page
- Nicholls, 2003, Lung pathology of fatal severe acute respiratory syndrome, Lancet, 361, 1773, 10.1016/S0140-6736(03)13413-7 · DOI · Paper page
- Wong, 2004, Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome, Clin Exp Immunol, 136, 95, 10.1111/j.1365-2249.2004.02415.x · DOI · Paper page
- Channappanavar, 2016, Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice, Cell Host Microbe, 19, 181, 10.1016/j.chom.2016.01.007 · DOI · Paper page
- Tang, 2008, IL-12 RB1 genetic variants contribute to human susceptibility to severe acute respiratory syndrome infection among Chinese, PLoS One, 3, e2183, 10.1371/journal.pone.0002183 · DOI
- Ip, 2005, Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection, J Infect Dis, 191, 1697, 10.1086/429631 · DOI · Paper page
- Franks, 2003, Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore, Hum Pathol, 34, 743, 10.1016/S0046-8177(03)00367-8 · DOI · Paper page
- Tse, 2004, Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS), J Clin Pathol, 57, 260, 10.1136/jcp.2003.013276 · DOI · Paper page
- Hsu, 2003, Severe acute respiratory syndrome in Singapore: clinical features of index patient and initial contacts, Emerg Infect Dis, 9, 713, 10.3201/eid0906.030264 · DOI · Paper page
- Booth, 2003, Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area, JAMA, 289, 2801, 10.1001/jama.289.21.JOC30885 · DOI · Paper page
- Peiris, 2003, The severe acute respiratory syndrome, N Engl J Med, 349, 2431, 10.1056/NEJMra032498 · DOI · Paper page
- Wong, 2004, Index patient and SARS outbreak in Hong Kong, Emerg Infect Dis, 10, 339, 10.3201/eid1002.030645 · DOI
- Yu, 2005, Temporal-spatial analysis of Severe acute respiratory syndrome among hospital inpatients, Clin Infect Dis, 40, 1237, 10.1086/428735 · DOI · Paper page
- Loon, 2004, The severe acute respiratory syndrome coronavirus in tears, Br J Ophthalmol, 88, 861, 10.1136/bjo.2003.035931 · DOI · Paper page
- Yu, 2004, Evidence of airborne transmission of the severe acute respiratory syndrome virus, N Engl J Med, 350, 1731, 10.1056/NEJMoa032867 · DOI · Paper page
- Chu, 2005, Viral load distribution in SARS outbreak, Emerg Infect Dis, 11, 1882, 10.3201/eid1112.040949 · DOI
- Yu, 2014, Severe acute respiratory syndrome beyond Amoy Gardens: completing the incomplete legacy, Clin Infect Dis, 58, 683, 10.1093/cid/cit797 · DOI
- Booth, 2005, Detection of airborne Severe acute respiratory syndrome (SARS) coronavirus and environmental contamination in SARS outbreak units, J Infect Dis, 191, 1472, 10.1086/429634 · DOI · Paper page
- Leung, 2004, The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients, Ann Intern Med, 141, 662, 10.7326/0003-4819-141-9-200411020-00006 · DOI · Paper page
- Peiris, 2003, Coronavirus as a possible cause of severe acute respiratory syndrome, Lancet, 361, 1319, 10.1016/S0140-6736(03)13077-2 · DOI · Paper page
- Leung, 2003, Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection, Gastroenterol, 125, 1011, 10.1016/j.gastro.2003.08.001 · DOI · Paper page
- Hung, 2003, Detection of SARS coronavirus RNA in the cerebrospinal fluid of a patient with severe acute respiratory syndrome, Clin Chem, 49, 2108, 10.1373/clinchem.2003.025437 · DOI · Paper page
- Lau, 2004, Possible central nervous system infection by SARS coronavirus, Emerg Infect Dis, 10, 342, 10.3201/eid1002.030638 · DOI · Paper page
- Wong, 2003, Severe acute respiratory syndrome (SARS) in a geriatric patient with a hip fracture. A case report, J Bone Joint Surg Am, 85A, 1339, 10.2106/00004623-200307000-00022 · DOI
- Hon, 2003, Clinical presentations and outcome of severe acute respiratory syndrome in children, Lancet, 561, 1701, 10.1016/S0140-6736(03)13364-8 · DOI · Paper page
- Wong, 2004, Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome, Am J Obstet Gynecol, 191, 292, 10.1016/j.ajog.2003.11.019 · DOI · Paper page
- Leung, 2006, Seroprevalence of IgG antibodies to SARS-coronavirus in asymptomatic or subclinical population groups, Epidemiol Infect, 134, 211, 10.1017/S0950268805004826 · DOI · Paper page
- Hui, 2004, Severe Acute Respiratory Syndrome (SARS): correlation of clinical outcome and radiological features, Radiology, 233, 579, 10.1148/radiol.2332031649 · DOI
- Hui, 2003, Severe acute respiratory syndrome: clinical features and diagnosis, Respirol, 8, S20, 10.1046/j.1440-1843.2003.00520.x · DOI
- Wong, 2003, Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis, Br Med J, 326, 1358, 10.1136/bmj.326.7403.1358 · DOI · Paper page
- Wong, 2003, Severe acute respiratory syndrome: radiographic appearances and pattern of progression in 138 patients, Radiology, 228, 401, 10.1148/radiol.2282030593 · DOI · Paper page
- Stroher, 2004, Severe acute respiratory syndrome-related coronavirus is inhibited by interferon-α, J Infect Dis, 189, 1164, 10.1086/382597 · DOI · Paper page
- Chu, 2004, Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings, Thorax, 59, 252, 10.1136/thorax.2003.012658 · DOI · Paper page
- Chan, 2003, Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicenter retrospective matched cohort study, Hong Kong Med J, 9, 399
- Cinatl, 2003, Treatment of SARS with human interferons, Lancet, 362, 293, 10.1016/S0140-6736(03)13973-6 · DOI · Paper page
- Hensley, 2004, Interferon-β 1a and SARS coronavirus replication, Emerg Infect Dis, 10, 317, 10.3201/eid1002.030482 · DOI · Paper page
- Haagmans, 2004, Pegylated interferon-α protects type 1 pneumocytes against SARS coronavirus infection in macaques, Nat Med, 10, 290, 10.1038/nm1001 · DOI · Paper page
- Loutfy, 2003, Interferon Alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study, JAMA, 290, 3222, 10.1001/jama.290.24.3222 · DOI · Paper page
- Jiang, 2005, Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome, Am J Respir Crit Care Med, 171, 850, 10.1164/rccm.200407-857OC · DOI · Paper page
- Sung, 2004, Severe Acute Respiratory Syndrome: report of treatment and outcome after a major outbreak, Thorax, 59, 414, 10.1136/thx.2003.014076 · DOI · Paper page
- Tsang, 2003, Coronavirus-positive nasopharyngeal aspirate as predictor for severe acute respiratory syndrome mortality, Emerg Infect Dis, 9, 1381, 10.3201/eid0911.030400 · DOI
- Wang, 2003, Fatal aspergillosis in a patient with SARS who was treated with corticosteroids, N Engl J Med, 349, 507, 10.1056/NEJM200307313490519 · DOI · Paper page
- Griffith, 2005, Osteonecrosis of hip and knee in patients with severe acute respiratory syndrome treated with steroids, Radiology, 235, 168, 10.1148/radiol.2351040100 · DOI · Paper page
- Lee, 2004, Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients, J Clin Virol, 31, 304, 10.1016/j.jcv.2004.07.006 · DOI · Paper page
- Soo, 2004, Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients, Clin Microbiol Infect, 10, 676, 10.1111/j.1469-0691.2004.00956.x · DOI · Paper page
- Cheng, 2005, Use of convalescent plasma therapy in SARS patients in Hong Kong, Eur J Clin Microbiol Infect Dis, 24, 44, 10.1007/s10096-004-1271-9 · DOI · Paper page
- Mair-Jenkins, 2015, The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis, J Infect Dis, 211, 80, 10.1093/infdis/jiu396 · DOI · Paper page
- Yu, 2007, Why did outbreaks of severe acute respiratory syndrome occur in some hospital wards but not in others?, Clin Infect Dis, 44, 1017, 10.1086/512819 · DOI · Paper page
- Tran, 2012, Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review, PLoS One, 7, e35797, 10.1371/journal.pone.0035797 · DOI · Paper page
- Zaki, 2012, Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia, N Engl J Med, 367, 1814, 10.1056/NEJMoa1211721 · DOI · Paper page
- World Health Organization, 2016, Middle East Respiratory Syndrome Coronavirus (MERS-CoV) – Qatar, Disease Outbreak News
- Annan, 2013, Human betacoronavirus 2c EMC/2012-related viruses in bats, Ghana and Europe, Emerg Infect Dis, 19, 456, 10.3201/eid1903.121503 · DOI · Paper page
- Memish, 2013, Middle East respiratory syndrome coronavirus in bats, Saudi Arabia, Emerg Infect Dis, 19, 1819, 10.3201/eid1911.131172 · DOI · Paper page
- Miguel, 2016, Absence of Middle East respiratory syndrome coronavirus in Camelids, Kazakhstan, 2015, Emerg Infect Dis, 22, 555, 10.3201/eid2203.151284 · DOI
- Chan, 2015, Absence of MERS-coronavirus in bactrian camels, southern Mongolia, November 2014, Emerg Infect Dis, 21, 1269, 10.3201/eid2107.150178 · DOI
- Hemida, 2014, Seroepidemiology of Middle East Respiratory Syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity, Euro Surveill, 19, 10.2807/1560-7917.ES2014.19.23.20828 · DOI
- Hemida, 2015, Dromedary camels and the transmission of Middle East Respiratory Syndrome Coronavirus (MERS-CoV), Transbound Emerg Dis, 10.3201/eid2104.141949 · DOI
- Hijawi, 2013, Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation, East Mediterr Health J, 19, S12, 10.26719/2013.19.supp1.S12 · DOI · Paper page
- Alraddadi, 2016, Risk factors for primary Middle East respiratory syndrome coronavirus illness in humans, Saudi Arabia, 2014, Emerg Infect Dis, 22, 49, 10.3201/eid2201.151340 · DOI · Paper page
- Drosten, 2014, Transmission of MERS-coronavirus in household contacts, N Engl J Med, 371, 828, 10.1056/NEJMoa1405858 · DOI · Paper page
- Arwady, 2016, Middle East respiratory syndrome coronavirus transmission in extended family, Saudi Arabia, 2014, Emerg Infect Dis, 22, 1395, 10.3201/eid2208.152015 · DOI · Paper page
- Müller, 2015, Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study, Lancet Infect Dis, 15, 559, 10.1016/S1473-3099(15)70090-3 · DOI · Paper page
- Oboho, 2015, 2014 MERS-CoV outbreak in Jeddah–a link to health care facilities, N Engl J Med, 372, 846, 10.1056/NEJMoa1408636 · DOI · Paper page
- Hunter, 2016, Transmission of Middle East respiratory syndrome coronavirus infections in healthcare settings, Abu Dhabi, Emerg Infect Dis, 22, 647, 10.3201/eid2204.151615 · DOI · Paper page
- Korea Centers for Disease Control and Prevention, 2015, Middle east respiratory syndrome coronavirus outbreak in the Republic of Korea, 2015, Osong Public Health Res Perspect, 6, 269, 10.1016/j.phrp.2015.08.006 · DOI · Paper page
- Oh, 2015, Middle east respiratory sayndrome coronavirus superspreading event involving 81 persons, Korea 2015, J Korean Med Sci, 30, 1701, 10.3346/jkms.2015.30.11.1701 · DOI · Paper page
- Zumla, 2014, Infection control and MERS-CoV in health-care workers, Lancet, 383, 1869, 10.1016/S0140-6736(14)60852-7 · DOI
- 2013, State of knowledge and data gaps of Middle East respiratory syndrome coronavirus (MERS-CoV) in humans, PLoS Curr, 5
- Guery, 2013, Clinical features and viral diagnosis of two cases of infection with middle east respiratory syndrome coronavirus: a report of nosocomial transmission, Lancet, 381, 2265, 10.1016/S0140-6736(13)60982-4 · DOI · Paper page
- Memish, 2013, Family cluster of middle east respiratory syndrome coronavirus infections, N Engl J Med, 368, 2487, 10.1056/NEJMoa1303729 · DOI · Paper page
- Algahtani, 2016, Neurological complications of middle east respiratory syndrome coronavirus: a report of two cases and review of the literature, Case Rep Neurol Med, 2016, 3502683
- Assiri, 2016, Middle east respiratory syndrome coronavirus infection during pregnancy: a report of 5 cases from Saudi Arabia, Clin Infect Dis, 63, 951, 10.1093/cid/ciw412 · DOI
- Alserehi, 2016, Impact of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) on pregnancy and perinatal outcome, BMC Infect Dis, 16, 105, 10.1186/s12879-016-1437-y · DOI · Paper page
- Malik, 2016, Middle east respiratory syndrome- coronavirus during pregnancy, Abu Dhabi, United Arab Emirates, 2013, Emerg Infect Dis, 22, 515, 10.3201/eid2203.151049 · DOI
- Payne, 2014, Stillbirth during infection with Middle East respiratory syndrome coronavirus, J Infect Dis, 209, 1870, 10.1093/infdis/jiu068 · DOI
- Drosten, 2013, Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection, Lancet Infect Dis, 13, 745, 10.1016/S1473-3099(13)70154-3 · DOI · Paper page
- Corman, 2016, Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection, Clin Infect Dis, 62, 477, 10.1093/cid/civ951 · DOI · Paper page
- Ajlan, 2014, Middle East respiratory syndrome coronavirus (MERS-CoV) infection: chest CT findings, AJR Am J Roentgenol, 203, 782, 10.2214/AJR.14.13021 · DOI · Paper page
- Lu, 2013, Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26, Nature, 500, 227, 10.1038/nature12328 · DOI · Paper page
- Müller, 2012, Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines, MBio, 3, 10.1128/mBio.00515-12 · DOI · Paper page
- Chan, 2013, Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: implications for disease pathogenesis and clinical manifestation, J Infect Dis, 207, 1743, 10.1093/infdis/jit123 · DOI · Paper page
- de Wilde, 2013, MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-α treatment, J Gen Virol, 94, 1749, 10.1099/vir.0.052910-0 · DOI · Paper page
- Falzarano, 2013, Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin, Sci Rep, 3, 1686, 10.1038/srep01686 · DOI · Paper page
- Chan, 2013, Tropism of and innate immune responses to the novel human betacoronavirus lineage C virus in human ex vivo respiratory organ cultures, J Virol, 87, 6604, 10.1128/JVI.00009-13 · DOI · Paper page
- Hocke, 2013, Emerging human middle east respiratory syndrome coronavirus causes widespread infection and alveolar damage in human lungs, Am J Respir Crit Care Med, 188, 882, 10.1164/rccm.201305-0954LE · DOI
- Faure, 2014, Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?, PLoS One, 9, e88716, 10.1371/journal.pone.0088716 · DOI · Paper page
- Poissy, 2014, Kinetics and pattern of viral excretion in biological specimens of two MERS-CoV cases, J Clin Virol, 61, 275, 10.1016/j.jcv.2014.07.002 · DOI
- Park, 2015, Kinetics of serologic responses to MERS coronavirus infection in humans, South Korea, Emerg Infect Dis, 21, 2186, 10.3201/eid2112.151421 · DOI · Paper page
- Payne, 2016, Persistence of antibodies against middle east respiratory syndrome coronavirus, Emerg Infect Dis, 22, 1824, 10.3201/eid2210.160706 · DOI · Paper page
- Ng, 2016, Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of middle east respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014, Am J Pathol, 186, 652, 10.1016/j.ajpath.2015.10.024 · DOI · Paper page
- Cha, 2016, A case report of a Middle East respiratory syndrome survivor with kidney biopsy results, J Korean Med Sci, 31, 635, 10.3346/jkms.2016.31.4.635 · DOI
- Zhou, 2014, Active replication of middle east respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis, J Infect Dis, 209, 1331, 10.1093/infdis/jit504 · DOI · Paper page
- Dyall, 2014, Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection, Antimicrob Agents Chemother, 58, 4885, 10.1128/AAC.03036-14 · DOI · Paper page
- De Wilde, 2014, Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture, Antimicrob Agents Chemother, 58, 4875, 10.1128/AAC.03011-14 · DOI · Paper page
- Falzarano, 2013, Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques, Nat Med, 19, 1313, 10.1038/nm.3362 · DOI · Paper page
- Al-Tawfiq, 2014, Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study, Int J Infect Dis, 20, 42, 10.1016/j.ijid.2013.12.003 · DOI · Paper page
- Shalhoub, 2015, IFN-α2a or IFN-β1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study, J Antimicrob Chemother, 70, 2129, 10.1093/jac/dkv085 · DOI · Paper page
- Omrani, 2014, Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study, Lancet Infect Dis, 14, 1090, 10.1016/S1473-3099(14)70920-X · DOI · Paper page
- Spanakis, 2014, Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen, Int J Antimicrob Agents, 44, 528, 10.1016/j.ijantimicag.2014.07.026 · DOI
- Rossignol, 2014, Nitazoxanide: a first-in-class broad-spectrum antiviral agent, Antiviral Res, 110, 94, 10.1016/j.antiviral.2014.07.014 · DOI · Paper page
- Arabi, 2014, Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection, Ann Intern Med, 160, 389, 10.7326/M13-2486 · DOI · Paper page
- Hui, 2013, Adjunctive therapies and immunomodulatory agents in the management of severe influenza, Antiviral Res, 98, 410, 10.1016/j.antiviral.2013.03.019 · DOI
- Chan, 2013, Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus, J Infect, 67, 606
- Chan, 2015, Treatment with lopinavir/ritonavir or interferon-β1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset, J Infect Dis, 212, 1904, 10.1093/infdis/jiv392 · DOI · Paper page
- AlGhamdi, 2015, MERS CoV infection in two renal transplant recipients: case report, Am J Transplant, 15, 1101, 10.1111/ajt.13085 · DOI
- Johnson, 2016, 3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3/2012, Virology, 490, 49, 10.1016/j.virol.2016.01.004 · DOI · Paper page
- Corti, 2015, Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus, Proc Natl Acad Sci U S A, 112, 10473, 10.1073/pnas.1510199112 · DOI · Paper page
- Jiang, 2014, Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein, Sci Transl Med, 6, 234ra59, 10.1126/scitranslmed.3008140 · DOI · Paper page
- Luke, 2016, Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo, Sci Transl Med, 8, 326ra21, 10.1126/scitranslmed.aaf1061 · DOI · Paper page
- Johnson, 2015, Intratracheal exposure of common marmosets to MERS-CoV Jordan-n3/2012 or MERS-CoV EMC/2012 isolates does not result in lethal disease, Virology, 485, 422, 10.1016/j.virol.2015.07.013 · DOI · Paper page
- Breban, 2013, Interhuman transmissibility of middle east respiratory syndrome coronavirus: estimation of pandemic risk, Lancet, 382, 694, 10.1016/S0140-6736(13)61492-0 · DOI · Paper page
- Hui, 2014, Advancing priority research on the middle east respiratory syndrome coronavirus, J Infect Dis, 209, 173, 10.1093/infdis/jit591 · DOI
Cited by
CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells
Wang, K., Chen, W., Zhang, Z., Deng, Y., Lian, J.-Q., Du, P., Wei, D., Zhang, Y., Sun, X.-X., Gong, L., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00426-x · Cited by 1,593
Wang, Y., Wang, Y., Chen, Y., & Qin, Q. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25748 · Cited by 1,531
Schwartz, D. A. (2020) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2020-0901-sa · Cited by 976
Schwartz, D. A., & Graham, A. L. (2020) · Viruses · doi:10.3390/v12020194 · Cited by 936
Zoonotic diseases: etiology, impact, and control
Rahman, M. T., Sobur, M. A., Islam, M. S., Ievy, S., Hossain, M. J., El Zowalaty, M. E., Rahman, A. T., & Ashour, H. M. (2020) · Microorganisms · doi:10.3390/microorganisms8091405 · Cited by 853
“MERS infections can cause significant mortality rates and deleterious public health impacts [139,140].”
Background
Metadata
- Authors
- Hui, D. S.
- Venue
- Clinics in Chest Medicine
- Publisher
- Elsevier BV
- Published
- 2017-03
- Volume
- 38
- Issue
- 1
- Pages
- 71-86
- ISSN
- 0272-5231 (ISSN-L)
- OpenAlex
- W2564025375
- Cited by
- 153
- References
- 12
- FWCI
- 1.68
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Epidemic and Emerging Coronaviruses (Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome). https://app.cochat.ai/papers/10.1016/j.ccm.2016.11.007
- The paper
- Hui, D. S. (2017). Epidemic and Emerging Coronaviruses (Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome). Clinics in Chest Medicine. https://doi.org/10.1016/j.ccm.2016.11.007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.